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Abstract
Multiple sclerosis is characterized by tissue atrophy involving the brain and the spinal cord, where reactive inflammation
contributes to the neurodegenerative processes. Recently, the presence of synapse alterations induced by the
inflammatory responses was suggested by experimental and clinical observations, in experimental autoimmune
encephalomyelitis mouse model and in patients, respectively. Further knowledge on the interplay between
pro-inflammatory agents, neuroglia and synaptic dysfunction is crucial to the design of unconventional protective
molecules. Here we report the effects, on spinal cord circuits, of a cytokine cocktail that partly mimics the signature of T
lymphocytes sub population Th1. In embryonic mouse spinal organ-cultures, containing neuronal cells and neuroglia,
cytokines induced inflammatory responses accompanied by a significant increase in spontaneous synaptic activity. We
suggest that cytokines specifically altered signal integration in spinal networks by speeding the decay of GABAA
responses. This hypothesis is supported by the finding that synapse protection by a non-peptidic NGF mimetic
molecule prevented both the changes in the time course of GABA events and in network activity that were left
unchanged by the cytokine production from astrocytes and microglia present in the cultured tissue. In conclusion, we
developed an important tool for the study of synaptic alterations induced by inflammation, that takes into account the
role of neuronal and not neuronal resident cells.
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Introduction
Inflammatory mechanisms have been closely linked to the
pathogenesis of heterogeneous diseases of the Central
Nervous System (CNS), including multiple sclerosis (MS),
Alzheimer’s disease (AD), amyotrophic lateral sclerosis
(ALS) and Parkinson’s disease (PD) [1, 2]. In these patholo-
gies, inflammatory cytokines (CKs) can be either delivered
by activated microglia and astrocytes (CNS resident cells)
or by peripheral immune cells able to infiltrate the CNS
parenchyma (lymphocytes, neutrophils and mast cells).
CKs release affects neurons and synapses, contributing to
gray matter pathology. In experimental multiple sclerosis
the harmful action of microglia on synaptic activity is
mediated by tumor-necrosis factor-alfa (TNF-α) and
interleukin-1beta (IL-1β), and pro-inflammatory condi-
tions in general have been reported to tune post-synaptic
NMDA and AMPA glutamate receptors, enhancing excita-
tory transmission and inhibiting the GABAergic one [3–5].
These observations have led to the awareness that multiple
sclerosis pathophysiology, traditionally viewed as a genuine
white matter autoimmune disorder with only secondary
neurodegenerative components [6], involves diffuse synap-
tic dysfunction and loss, i.e. synaptopathy, that concur-
rently with demyelination contributes to grey matter
atrophy. Inflammatory-dependent synaptopathy, reviewed
by Mandolesi et al. (2015), has been detected in MS
patients, representing a novel and promising target for
future therapies [7].
Nerve growth factor (NGF), extensively studied as
neuro-protector agent in neurodegenerative diseases [8], is
involved in neuronal survival and reparative processes.
NGF has been reported to confer CNS protection in
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experimental autoimmune encephalomyelitis (EAE) [9].
Recently, Xu et al. (2016) described the neuroprotective ef-
fects of a molecule (T-006) that mimic NGF activities and
potentiates NGF-protection against glutamate-induced
excitotoxicity [10]. In accordance to these strategies, the
strongest rationale behind mesenchymal stem cell (MSC)
transplantation as an effective therapeutic approach in MS,
AD, PD and ALS, resides also in MSCs ability to secrete
neurotrophic factors, preventing neuronal damage induced
by the inflammatory insult [11]. In the development of
novel therapies, the design of trophic molecules able to
cross the blood brain barrier (BBB) and thus to directly
target neurons, shielding them from synaptic alterations, is
a timely placed issue.
Mechanistic studies of the interplay between the release
of CKs, the activation of microglia, the emergence of
synaptic dysfunction and the role of novel protective
molecules, may require sophisticated in vitro models
tested in the laboratory to investigate CNS responses at
synaptic resolution.
Organotypic slice cultures developed from the embry-
onic mouse spinal cord represent a complex in vitro
model where sensory-motor cytoarchitecture, synaptic
properties and spinal cord resident cells are retained in a
3D–fashion [12, 13]. By the use of this model, we have
recently shown that in the SOD1G93A mouse, a genetic
ALS model, spinal synapses retain greater GABA and
glycine co-release than in the wild types and these
changes influenced synaptic integration [14].
Here, we further exploit organotypic cultures from the
embryonic mouse spinal cord to monitor the emergence
of synaptopathy in pre-motor circuits following CKs
transient exposure, and to test the neuroprotective
efficacy of NGF-mimetic molecule MT2 [15].
We monitored synaptic activity by patch-clamp record-
ing of visually identified ventral interneurons. Spinal
cultured tissue exposed to a cocktail of pro-inflammatory
CKs displayed a significant increase in spontaneous synap-
tic activity characterized by a speeding up of the decay
phase of GABAergic inhibitory currents, that may affect
temporal precision at post-synaptic site and synaptic
control of network excitability. These changes were accom-
panied by significant production of cytokines and chemo-
kines, astrogliosis and microglia activation. Although these
inflammatory features were untouched by MT2 applica-
tions, this drug reverted all synaptic changes, suggesting
the need of specific neuro-protective strategies during
chronic inflammation in the CNS.
Results
Organotypic spinal cord cultures express TrkA and TrkB
receptors
Organotypic spinal slices represent a biological model use-
ful for studying the dynamics of intra-segmental processes
that evidently rely on resident neuroglial cells, propriosp-
inal neurons and circuits [12–14]. To investigate the
impact of inflammation on spinal synaptic networks we
used co-cultured mouse DRG and spinal cord explants
after 2 weeks of in vitro growth (Fig. 1a). These cultures
contain heterogeneous cell populations belonging to the
neuronal and neuroglial phenotypes [12], including
GFAP-positive astrocytes and Iba1-positive microglia
(Fig. 1b). We exploited this model to evaluate the NGF-
mimetic molecule MT2 ability to prevent synaptic modu-
lation brought about by neuroinflammation, the latter
induced by incubating (for 4 and 6 h) the tissue with pro-
inflammatory CKs (TNF-α, IL-1β and GM-CSF, 10 ng/
mL) [16]. Since MT2 is a ligand of TrkA and TrkB recep-
tors, we first checked the expression of these receptors in
the cultured slices. Figure 1c shows the western blot
analysis obtained under basal conditions and upon CK
stress in the presence or in the absence of MT2 (10 μM).
We found that both receptors are expressed by organoty-
pic cultures, and the levels of expression were comparable
in all the experimental conditions. By immunofluores-
cence labeling (Fig. 1d) we observed that TrkA and TrkB
are mainly expressed by DRG neurons and with TrkB, in
part, by astrocytes (Fig. 1e).
NGF-mimetic MT2 counteracts CKs induced increase in
synaptic activity in organotypic slices
We triggered the neuro-inflammatory stress by incubating
organotypic cultures with a cocktail of CKs. To directly
assess the presence of changes at the level of spinal
network activity we patch clamped visually identified ven-
tral interneurons and compared, under voltage clamp
mode, the emergence of heterogeneous spontaneous post-
synaptic currents (sPSCs; Fig. 2a) between control (CTRL;
n = 48) and treated cultures (CKs4H and CKs6H; n = 32
and n = 34, respectively). Organotypic spinal slices display
prominent spontaneous electrical activity in the ventral,
premotor area [13, 14]. To enable a meaningful compari-
son of the shifts in communication dynamics in networks
exposed to CKs, we selected the 2 WIV stage, where
neurons are known to exhibit an intense synaptic activity
[13, 14]. In all culture groups, sPSCs were represented by
heterogeneous inward currents of variable amplitudes
(Fig. 2a and b). CKs treatments did not affect neuronal
passive membrane properties (see Methods), however both
CKs incubation protocols significantly increased the fre-
quency of sPSCs. The plot in Fig. 2c shows (small symbols)
data for six different culture series (between 5 and 8 cells
in CTRL and CK4H or CK6H for each series), and the dif-
ference in mean values, reported as larger symbols, is sta-
tistically significant (19.1 ± 12.7 Hz CTRL; 29.6 ± 10.0 Hz
CKs4H; 31.7 ± 14.7 Hz CKs6H; **P = 0.0048 CTRL vs
CKs4H and **P = 0.0002 vs CKs6H, two-way ANOVA).
This result is in agreement with previous works reporting
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the ability of pro-inflammatory CKs, such as TNF-α or IL-
1β, to enhance synaptic transmission in spinal cord acute
slices [17–19]. However, differently from other studies [20,
21], the neuroinflammatory milieu did not affect the
frequency and amplitude of miniature (recorded in the
presence of TTX, 1 μM), pharmacologically isolated (in
the presence of bicuculline 20 μM and strychnine 1 μM),
AMPA-glutamate receptor-mediated excitatory PSCs
(mEPSCs; CTRL n = 37, CKs4H n = 20, CKs6H n = 20;
Fig. 2d). mEPSCs are independent of network function and
should primarily help to localize observed changes in
synaptic transmission to pre- and/or post-synaptic level.
Our results suggest that CKs treatments were not affecting
network activity by tuning excitatory synapses at the
pre-synaptic level, increasing the probability of release or
the number of release sites, or at the post-synaptic one,
altering the properties of glutamate receptors [22].
In parallel, we tested the effects of MT2 applications
prior and during CKs 4H and 6H treatments (Fig. 2b).
MT2 did not affect the passive properties of CTRL spinal
neurons (see Methods) that exhibited a variable and slight,
although not significant (P = 0.3292), increase in sPSCs
frequency (24.5 ± 14.1 Hz CTRL +MT2, n = 43), as sum-
marized in the plot of Fig. 2c. In the presence of MT2,
Fig. 1 TrkA/B receptor expression in organotypic spinal cord cultures. a Low magnification immunofluorescence for SMI32 (green) of an organotypic
spinal cord slice cultured for 2 weeks. The arrow indicates the ventral fissure, localizing the ventral horns. Note the co-cultured DRGs (arrow heads).
Calibration bar 500 μm. b High magnification immunofluorescence labeling for microglia, astrocytes, and neurons, details of the ventral horn (left) or
DRG (right) are shown. Left) green: Iba1 (microglia); red: GFAP (astrocytes). Right) green: GFAP (astrocytes); magenta: SMI-32 (neurons). Calibration bar
20 μm. c Western blot analysis of Tropomyosin receptor kinases A and B (TrkA and TrkB) expression in organotypic cultures stimulated with a cocktail
of pro-inflammatory CKs (TNF-α, IL-1β and GM-CSF, 10 ng/ml each) for 4 or 6 h in the presence or in the absence of NGF-mimetic molecule
MT2 (10 μM). GAPDH was used as house-keeping gene. Each well of the electrophoresis gel was loaded with an equal amount of proteins
extracted from a pull of n = 5 organotypic slices. Note that TrkA and TrkB expression is not affected by treatments. This experiment is representative of
3 independent ones. d Immunofluorescence confocal and differential interference contrast (DIC) images for TrkA and TrkB expression in DRG neurons.
Green: TrkA (left panel), TrkB (right panel). Red: SMI-32. Yellow: merge. Calibration bar 50 μm. e Immunofluorescence confocal images for TrkB and
GFAP in the ventral horns. Green: TrkB; magenta: GFAP Calibration bar 20 μm
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CKs treatments at both 4H (n = 40) and 6H (n = 40) did
not further boost sPSCs frequency (26.8 ± 11.5 Hz CKs4H
+MT2; 26.6 ± 12.8 Hz CKs6H +MT2). MT2 ability to
control the increase in sPSCs frequency brought about by
CKs treatments is summarized in the inset of Fig. 2c,
where the frequency of synaptic currents is expressed as %
of each control.
mEPSCs frequency and amplitude were unchanged
when measured in the presence of MT2, with or without
CKs (see Additional file 1: Figure S1). These results sup-
port the hypothesis that MT2 prevented the increase in
network activity caused by the inflammation milieu,
apparently without targeting at the pre or post-synaptic
level the AMPA receptor mediated synapses.
In the next set of experiments we explored fast Cl− me-
diated synaptic transmission and, because of the relatively
low frequency of glycinergic events at this developmental
stage in culture [13], we compared CTRL (n = 16) vs CKs
treated GABAA receptor-mediated synaptic events
(IPSCs), recorded in the presence of CNQX (10 μM),
APV (25 μM) and strychnine (1 μM). Upon CKs treat-
ments at 4H (n = 13) and 6H (n = 11) IPSC frequency (4.6
± 3.0 Hz CTRL; 4.9 ± 2.3 Hz CKs4H; 4.7 ± 3.1 Hz CKs6H)
and amplitude (20.1 ± 8.9 pA CTRL; 20.7 ± 9.5 pA CKs4H;
Fig. 2 Pro-inflammatory CKs modulation of synaptic activity in organotypic spinal cord cultures is prevented by MT2. In (a) and (b) Spontaneous
PSCs (sPSCs) recorded from organotypic spinal cord ventral interneurons in control (CTRL) or after CKs treatments in the absence in (a) or in the
presence in (b) of MT2. Note that CKs ability to increase sPSCs occurrence is prevented by MT2 applications. c The plot summarizes the frequency
of sPSCs prior and after CKs incubation, note the significant increase in network activity, and the frequency of sPSCs prior and after CKs incubation in
the presence of MT2, note the absence of significant changes in network activity. Small symbols depict data for six different culture series (between 5
and 8 cells each); larger symbols report mean values. In the inset: the frequency of sPSCs is expressed in respect to each control group, note the
increase by 55.27% in CKs4H and by 65.94% in CKs6H. Virtually no increases were observed in MT2: 9.20% in CKs4H +MT2 and 8.63% in CKs6H +MT2.
d Box-plots summarize the mEPSC event frequency and amplitude values in control or after CKs treatments. Note that CKs applications did not affect
these parameters. See the Additional file 1: Figure S1 for mEPSCs in MT2 control and MT2 CKs-treated organotypic slices
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25.2 ± 13.6 pA CKs6H) were not changed by the
inflammatory conditions in control or in the presence of
MT2 (sample tracings in Fig. 3a and b; box plots in
Additional file 2: Figure S2; CTRL +MT2 n = 16, CK4H +
MT2 n = 14, CK6H +MT2 n = 18).
Superimposed IPSCs in Fig. 3a (right), show that their
decay time constant (τ) becomes progressively shorter
with CKs treatments. In Fig. 3c the box plot summarizes
the measured τ values (32.3 ± 7.8 ms CTRL; 24.3 ±
4.7 ms CKs4H; 21.8 ± 5.6 ms CKs6H; *P = 0.020 CTRL
vs CKs4H, **P = 0.0014 CTRL vs CKs6H, two-way
ANOVA; scaled IPSCs average are superimposed, top).
The absence of a significant correlation between IPSC
rise time vs decay time values (CTRL r = 0.3693; CKs4H
r = −0.1897; CKs6H r = 0.3419; CTRL +MT2 r = 0.3629;
CKs4H +MT2 r = 0.4652; CKs6H +MT2 r = 0.4420;
plots in Additional file 2: Figure S2) suggests that
differences in recording conditions, location of synapses
or electronic filtering are unlikely to have affected our
observations. We extend our characterization to the
properties of miniature IPSCs (mIPSCs; recorded in the
presence of TTX). The results in this group of cells
confirm that upon CKs treatments mIPSCs differ in
their decay kinetics (45.0 ± 8.6 ms CTRL; 31.2 ± 10.4 ms
CKs4H; 21.9 ± 2.1 ms CKs6H; *P = 0.024 CTRL vs
CKs6H, n = 4 for each of the three groups, one-way
ANOVA; Additional file 3: Figure S3) in a manner simi-
lar to that of spontaneous IPSCs. In the presence of
MT2, IPSCs show comparable τ in all CKs treatments,
as exemplified by the superimposed events in Fig. 3b.
The τ values are summarized in the box plot of Fig. 3c
(27.5 ± 7.7 ms CTRL +MT2, 27.8 ± 4.7 ms CKs4H +
MT2, 26.8 ± 7.2 ms CKs6H +MT2; scaled IPSCs average
are superimposed, bottom). The changes in GABAergic
Fig. 3 Pro-inflammatory CKs modulation of GABAA receptor-mediated event time course is prevented by MT2. Representative traces of IPSC recorded
from organotypic spinal slices prior and after CKs treatments in control (a) and in the presence of MT2 (b). Note that while CKs did not increase IPSC
frequency, they affected IPSC time course (superimposed tracings). c Box-plots summarize the decay time constant values in all conditions, in the insets
the scaled and superimposed average IPSC are depicted (control in black, CKs 4H in red and 6H in blue) in the absence or in the presence of MT2.
Note that in the presence of MT2 no changes in the IPSC time course were detected following CKs treatments. In the inset: the τ is expressed as % in
respect to each control group, note the reduction by 24.59% in CKs4H and by 32.48% in CKs6H. Virtually no decreases were observed in MT2: slight
increase by 1.12% in CKs4H +MT2 and slight reduction by 2.44% CKs6H +MT2. See the Additional file 2: Figure S2 for GABAergic PSCs in the absence
or in the presence of MT2
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τ induced by CKs treatments are summarized in the
inset of Fig. 3c, reported as % of changes in respect to
each control.
We can hypothesize that the MT2 was actually able to
protect inhibitory synapses from pro-inflammatory
stimulation.
Both CKs and MT2 are not interfering with spinal neurons
excitability
To elucidate the neuronal mechanisms mediating neuro-
inflammatory increase in spinal activity, we addressed
whether CKs changed neuronal excitability. In current
clamp mode, recorded interneurones did not differ in
terms of resting membrane potential and firing thresh-
old (see Methods). Ventral interneurons in organotypic
slices have been identified on the basis of their discharge
patterns [13]. We identified four different classes of in-
terneurons on the basis of their firing pattern (Fig. 4a)
[13, 23–26]: ‘transient’ cells, that generated a single AP
only; ‘adapting’ cells, that discharged an early burst of
APs followed by adaptation; ‘irregular’ cells without
discernible pattern of AP discharge; ‘tonic’ cells, that
continuously fired APs without apparent accommoda-
tion. A fifth category (i.e. ‘delay’ cells, that generated APs
after a lag) [13] was rarely (< 4%) observed and thus was
not quantified in these series of experiments.
We used depolarizing current steps (0.1 and 0.2 nA
amplitude) [13] to induce the firing patterns. The
histograms depicted in Fig. 4b report the similar
distribution of discharge patterns in CTRL and CK4H
(CTRL 16% transient, 64% adapting, 10% irregular,
10% tonic, n = 31; CKs4H 24% transient, 44% adapt-
ing, 16% irregular, 16% tonic, n = 25) and such a
Fig. 4 Pro-inflammatory CKs and MT2 do not alter neuronal excitability in organotypic spinal slices. a Discharge patterns of ventral interneurons.
The 500 ms depolarizing current commands induced different discharge patterns that identified four cell categories: transient, adapting, irregular
and tonic. b Bar-charts illustrate the probability distribution (expressed as percentage of sampled population) of each cell type in the various conditions
in the absence (left) or in the presence (right) of MT2. c Box-plots illustrate the absence of changes in the frequency of spontaneous action potentials
in all conditions tested
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distribution was not affected by MT2 treatments
(CTRL +MT2 19% transient, 52% adapting, 16%
irregular, 13% tonic, n = 31; CKs4H +MT2 14% transi-
ent, 53% adapting, 11% irregular, 22% tonic, n = 36).
The only different value observed was the virtual
absence in CKs6H of transient firing cells, on the
contrary well represented in CKs6H +MT2 (CKs6H
0% transient, 62% adapting, 11% irregular, 27% tonic,
n = 26; CKs6H +MT2 22% transient, 59% adapting,
3% irregular, 16% tonic, n = 37).
The box plots in Fig. 4c quantify the frequency of
spontaneous APs, and also in this case no differences
were detected among CTRL and CKs treated (CTRL
0.7 ± 0.8 Hz, n = 14; CKs4H 0.9 ± 0.8 Hz, n = 14;
CKs6H 1.0 ± 1.1 Hz, n = 12) or CTRL +MT2 and CKs
+MT2 (CTRL +MT2 1.3 ± 0.9 Hz, n = 14; CKs4H +
MT2 0.8 ± 0.8 Hz, n = 18; CKs6H +MT2 1.0 ± 1.0 Hz,
n = 13).
These results suggest that cell excitability was not af-
fected by CKs or MT2.
Inflammatory stress modifies cytokine and chemokine
production and induces astrogliosis
We evaluated the production of cytokines and chemo-
kines by organotypic spinal cord slices in response to
pro-inflammatory stress. The summarizing plots of
Fig. 5a show that the exposure to Th1 cytokine cock-
tail significantly increases the release of IL6 and IL10,
key players in regulating inflammation, as well as the
release of CXCL1, CXCL2 and CCL2, chemokines
implicated in the recruitment of innate immune cells
(*0.01 < P < 0.05; **0.001 < P < 0.01; ***P < 0.001; one-
way ANOVA). CXCL10, a T cell chemoattractant, is
not affected by these treatments. MT2, independently
on the inflammatory stimulation, does not exert any
effect in the release of any analyzed soluble factor. As
expected, the altered cytokine profile induced by
pro-inflammatory stress is accompanied by marked
astrogliosis and microglia activation, qualitatively
illustrated in the example of Fig. 5b (compare with
Fig. 1b).
Fig. 5 Effects of pro-inflammatory stress on soluble factor production and on astro/microglia morphology in organotypic spinal slices. a Production of
cytokines (IL6; IL10) and chemokines (CXCL1; CXCL2; CCL2; CXCL10) determined by Milliplex assay in organotypic culture supernatants after stimulation
with the pro-inflammatory cytokine cocktail (CKs) for 4 or 6 h in the presence or absence of MT2. Column graphs report mean values ± SEM of 25
independent experiments. The pro-inflammatory stimulus significantly increases the release of IL6, IL10, CXCL1, CXCL2 and CCL2 compared to control
(first column), both after 4 and 6 h of treatment. MT2 treatment did not alter the soluble factor production. b Immune fluorescence staining
for astrocytes (GFAP, green) and microglia (CD68, red). The pro-inflammatory stress (CKs) induces astrocyte spreading and microglia activation,
as indicated by the amoeboid shape. MT2 treatment did not affect these cellular patterns. The pictures show one field representative of 5 randomly
analyzed ones (one experiment representative of 5 independent ones). Calibration bar 20 μm
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MT2 modulates p38 MAPK activation induced by
cytokine stress
It is generally accepted that many highly conserved
serine/threonine mitogen-activated protein kinases
(MAPK), including p38 MAPK, are activated in response
by environmental and cellular stresses including CKs
[15]. We investigated the interplay between MT2 treat-
ment and p38 MAPK activation in organotypic slices
undergoing pro-inflammatory cytokines incubation.
Fig. 6a shows the result of western blot analysis with
specific antibody to phospho-p38 MAPK performed in
lysates of organotypic slices subjected to CKs stimuli.
The data show a de-phosphorylation of p38 MAPK in
MT2 treated slices. To better understand the modula-
tion of p38 MAPK activation elicited by MT2, we tested
whether MKP-1, a phosphatase highly specific for p38
MAPK and also for JNK, could have a role in this set-
ting. Figure 6b shows that, at 6H CKs treatment, MT2
caused an increase in MKP-1 expression. Taken together
these data suggest that MT2 has trophic effects on slices
undergoing metabolic derangement induced by pro-
inflammatory cytokines.
Discussion
The dogma of the CNS immune-privilege is progressively
weakening. In the last decade, an increasing amount of re-
sults suggested that, notwithstanding its being surrounded
by the BBB, the CNS is a highly immunological active
organ, characterized by complex immune cell activation
[27] resulting in beneficial (protective) as well as harmful
(degenerative) responses [28].
Inflammation, synaptic transmission and neuronal
damage are ultimately linked [7]. In this work we have
investigated pro-inflammatory CKs effects in spinal mi-
crocircuits developed in organotypic cultures containing
microglia, astrocytes and neurons, focusing on synaptic
activity and measuring soluble factor production. Last,
we exploited this model to demonstrate the synaptic
protective role of neurotrophins by treating the culture
with a non-peptidic mimetic molecule (MT2) that binds
TrkA/B receptors.
We selected a CKs cocktail able to mimic an inflam-
matory reaction that spreads in CNS containing IL-1β,
well known determinant of neuropathy [3, 7], TNF-α,
that is ubiquitary present during Th1/Th17 mediated
inflammatory reactions, and GM-CSF, key cytokine
responsible of pro-inflammatory effects in the CNS of
MS animal models [29]. GM-CSF receptors are
expressed in microglia, therefore the use of this soluble
factor allows targeting resident microglial cells, present
within the organotypic spinal explanted tissue. Indeed,
one of our aims was that to address synaptic function
in CNS circuits in the presence of astrocytes and
microglia exposed to CKs. We used factors known to
be released in EAE and able to directly and indirectly
(via activation of resident cells) target neuronal func-
tions. We adopted relatively acute treatments, which
triggered inflammatory responses, without affecting neur-
onal membrane properties or inducing direct neurotox-
icity, yet still able to alter synaptic transmission. This
protocol has allowed unmasking subtle early changes in
GABAergic synaptic currents, a significant player in the
excitation/inhibition balance of pre-motor outputs.
Fig. 6 Effects of MT2 on MAP Kinase pathway in organotypic spinal slices. Organotypic cultures were stimulated with pro-inflammatory CKs cocktail
for 4 or 6 h, in the presence or in the absence of MT2. a Slices lysates were blotted with rabbit anti-P-p38 and mouse anti-Tubulin as loading control.
Bar-charts represent the data of densitometric analysis and are expressed as the ratio between phospho-p38 and Tubulin proteins. b Slices lysates were
blotted with rabbit anti-MkP-1 and rabbit anti-ERK 1/2 as loading control. The bar-charts represent the data of densitometric analysis and are expressed
as the ratio between MKP-1 and ERK 1/2 proteins
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Pro-inflammatory CKs tune the excitability of organotypic
pre-motor circuit
In organotypic spinal tissue we confirmed the presence of
heterogeneous neuroglial cells after 2 weeks of in vitro
growth [9], and we further documented the expression
and cell-localization of TrkA/B receptors (see below). In
the present study, we have used a CKs cocktail and set a
tissue exposure protocol to these agents that did not alter
TrkA/B receptor expression, however such agents induced
a reliable release of cytokines and chemokines, mostly due
to the local generation and delivery of inflammatory
factors. In fact, upon CKs stimulus, we reported clear
inflammatory tissue reactivity expressed as IL6 and mono-
cytes recall-chemokines release, likely requiring the
involvement of the heterogeneous cell types present in the
slice culture. Our experimental model is ideally suited to
dissect spinal resident cells ability in modulating local
synapses, in the absence of any contributions from the
peripheral infiltrating cells, this mimics early phases of
multiple sclerosis where immune cells in brain perivascu-
lar spaces activate and produce inflammatory CKs that
easily diffuse before cells enter the CNS [30]. In particular,
CNS cultured explants allow investigating complex synap-
tic networks preserving the basic cytoarchitecture of the
original CNS area [31], but, differently from acute slices,
long term culturing allows the complete recovery from
the altered metabolic state caused by the tissue dissection
and promotes the effective clearance from the tissue
debris, due to the slicing procedure [32, 33].
We recorded from interneurons to assess how the
pro-inflammatory stress may regulate the ventral (pre-
motor) [14] circuit activity, and this was done within a
time-frame where the inflammatory pathological process
did not progress to the extent of excitotoxicity. The lack
of clear cell damage was supported by the absence of
changes in the values of resting membrane potential, in-
put resistance, cell capacitance and AP threshold in the
treated neurons in respect to control ones [34–36].
The present data show that, after 4 and 6 h CKs treat-
ments, the frequency of sPSCs was increased. An in-
creased synaptic transmission is a described feature of
pro-inflammatory stress in neural circuits, reported form
ex-vivo CNS slices isolated from EAE mouse models or
from healthy slices exposed to cerebrospinal fluid from
multiple sclerosis patients [3, 5, 37] as well as from acute
spinal cord slices transiently exposed to various pro-
inflammatory molecules [17–19]. Such increases in
synaptic transmission have been attributed to the up-
regulation of the glutamatergic system [3, 5, 37], to the
down-regulation of inhibitory transmission [17, 18, 38]
or to altered cell excitability [19, 39]. In spinal cultured
slices we did not detect the signatures of any of these
mechanisms. To understand the reason for the observed
boost in spinal network activity, we examined the
miniature excitatory currents [22] that did not suggest
the presence of changes in pre-synaptic release probabil-
ity and in the number of synaptic contacts or in post-
synaptic receptor sensitivity in glutamatergic synapses
due to CKs exposure, we also excluded alterations in
single cell excitability. We equally ruled out variations in
the general distribution of firing patterns [13, 19] and in
the frequency or amplitude of IPSCs.
We focused our attention to the fast Cl−-mediated
neurotransmission due to GABAA receptor activation,
recently indicated as a specific CKs target in spinal cir-
cuits [17, 19, 39]. Intriguingly, we found that both IPSCs
and mIPSCs from 4 and 6 h CKs slices decayed faster
than those from controls, in the absence of any other
changes, including differences in release synchronization
[14]. This is, to our knowledge, the first time that such a
modulation of GABAergic activity is reported due to
pro-inflammatory CKs exposure. We did not further
investigate in the present work the mechanisms respon-
sible for the altered kinetic properties of GABAergic
receptors and therefore the IPSC time course, which can
involve differences in the intracellular chloride concen-
tration [40, 41] as well as changes in the receptor
subunit composition [42].
Regardless the mechanisms involved, our experimental
conditions unmasked a sophisticated and specific synaptic
regulation during inflammatory states that may contribute
to the increase pre-motor circuit excitability via network-
mediated mechanisms. In fact, the faster decaying
GABAergic PSCs will lead to weaker and shorter-lasting
inhibition, resulting in a reduction in charge transfer in
the range 28–35%, perhaps associated with increased
network activity. This hypothesis is in agreement with the
MT2 ability to control both the CK-mediated increase in
network activity and the reduction in IPSC decay. It is
tempting to speculate that the different CKs cocktail, the
duration of the exposure used here, longer than in the
previous studies on acute spinal slices [17, 19, 39], and, in
particular, the presence of resident cells, are all factors
ultimately responsible of this divergence from previous
results. In addition, when compared to acute slicing, the
presence of full metabolic recovery from dissection in
organ cultures, might also play a significant role.
Interestingly, in previous reports, in dissociated cultures
exposed to inflammatory cues [38], the involvement,
during chronic EAE phases, of perturbed GABAergic
transmission, was suggested together with the need of
alternative neuroprotective strategies.
MT2 protective effect on spinal organotypic cultures
With the aim to restore spinal network activity following
the neuroinflammatory treatment, we turned our atten-
tion to NGF. NGF is a well-known regulator of neuronal
differentiation and plasticity [43]. More recently, NGF
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has been associated to inflammation and autoimmune
diseases. NGF, via TrkA receptors, down-regulates in-
flammatory CKs production while inducing the release
of anti-inflammatory mediators [44]. Moreover, adminis-
tration of NGF in vivo in EAE animals delays the onset
of clinical symptoms and prevents the full development
of EAE lesions [45–48]. Despite these exciting reports,
the therapeutic use of neurotrophins is a daunting task,
due to their limited ability to diffuse in tissues [15]. There-
fore, the design of small molecules able to interact with neu-
rotrophins receptors is of great therapeutic interest. In our
cultures, TrkA is specifically expressed in DRG and other
neurons; on the other hand, we found TrkB expression also
in astrocytes. TrkB expression in cultured DRG was not
unexpected [49], reviewed in [50]; the finding of TrkB ex-
pression in astrocytes is, although surprising for cultured
tissue, reminiscent of the complexity of the CNS in vivo. In
fact, in the adult rodent spinal cord TrkB expression has
been described in reactive astrocytes [51–53]. We did not
detect TrkB in CD68+ microglia, present in our culture
mostly in amoeboid (activated) form after CKs treatments,
in agreement with a previous report on the spinal cord
[54–56]. Notwithstanding TrkB expression in the organoty-
pic GFAP-positive astrocytes, (probably the main source of
IL-6), the sole addition of MT2 did not modify CK profile
in the supernatants, neither directly nor by neuron medi-
ated immune modulation [57]. However, MT2 controlled
the CKs electrophysiological signature, namely the induced
increase in the sPSCs frequency and the modulation of
IPSC time course. To note, MT2 provoked a slight increase
in synaptic activity per se, although not significant, and one
could argue that in this manner the CKs potentiating effect
was simply occluded. Against this interpretation, we also re-
ported the efficacy of MT2 in preventing IPSC decay time
modulation. Previous observations [15] suggested the possi-
bility of relatively fast transduction events, after engaging
the tyrosine kinase receptors; such mechanisms may explain
the short time (no more than 4 h) needed in order to ob-
serve the MT2 counteracting effect on electrophysiological
alterations. We also reported a trend of decrease in p-p38
accompanied by an increase in MKP-1. These results are,
although preliminary, suggestive of such pathways involve-
ment in rescuing GABAergic PSCs.
In conclusion, we developed an important tool for the
study of spinal cord alterations induced by inflammation,
that takes into account the role of resident cells: neur-
onal and not neuronal populations, this tool allowed us
to test a potential therapeutic molecule.
Methods
Preparation of spinal cord organotypic cultures and
neuroinflammation treatments
Briefly, organotypic slice cultures of spinal cord and dorsal
root ganglia (DRG) were obtained from mouse embryos
(C57BL/6 J of either sex) at days 12–13 of gestation as
previously described [13, 14, 58, 59]. Pregnant mice were
sacrificed by CO2 overdose and fetuses delivered by cae-
sarean section. Isolated fetuses were decapitated and their
backs were isolated from low thoracic and high lumbar
regions and transversely sliced (275 μm) with a tissue
chopper. After dissecting the spinal cord slices from the
surrounding tissue, slices were embedded into a thick
matrix obtained by chicken plasma (Rockland) and throm-
bin (Sigma) clot. Slices were cultured in plastic tubes with
1 mL medium [14]. The tubes were kept in a roller drum
rotating 120 times per hour in an incubator at 37 °C in
the presence of humidified atmosphere, with 5% CO2. Ex-
periments were performed on spinal cultures at 2-weeks
in vitro (WIV). The day of the experiment, organotypic
spinal cord slices were incubated with standard medium
(Control, CTRL) or, for 4 or 6 h (4H and 6H), with a
cocktail of the following mouse recombinant cytokines:
TNF-α (R&D Systems, #210-TA/CF), IL-1β (R&D
Systems, #M15330), and granulocyte-macrophage colony-
stimulating factor (GM-CSF; R&D Systems, #P04141),
10 ng/mL each, in order to induce an inflammatory state
(Hanisch, 2002). CKs were removed after 4H and 6H,
prior to electrophysiological recordings. In sister cultures,
controls and the incubation with the CKs cocktail was
done in the presence or absence of MT2, a NGF mimetic
non-peptidic TrkA and TrkB ligand, kind gift from Mime-
Tech srl, Rome, Italy. MT2 (10 μM for 4H) was tested in
the same three conditions (CTRL, CKs4H and CKs6H; in
CKs6H condition, MT2 was added after the first 2H of
the CKs treatment).
Immunofluorescence and microscopy
Organotypic cultures were fixed in 4% formaldehyde (pre-
pared from fresh paraformaldehyde; Sigma) in PBS for 1 h
at room temperature (RT; 20–22 °C), washed in PBS and
incubated at RT for 1 h in blocking/permeabilizing solu-
tion consisting of 3% FBS and 3% BSA (Sigma) and 0.3%
Triton-X 100 (Sigma) in PBS. Then, slices were incubated
over night at 4 °C with a combination of the following
primary antibodies, diluted in blocking/permeabilizing
solution: mouse monoclonal anti-glial fibrillary acidic
protein, (GFAP; Sigma, #G3893, RRID:AB_477010, 1:200);
rabbit polyclonal anti-ionized calcium-binding adapter
molecule 1, (Iba1; Wako, #019–19,741, RRID:AB_839504,
1:400); rat monoclonal CD68 (Abcam, #ab53444, RRI-
D:AB_869007, 1:200), rabbit polyclonal against Tropomy-
osin receptor kinase A (TrkA), (Santa Cruz, #SC-14024,
RRID:AB_2298807, 1:200); rabbit monoclonal against
Tropomyosin receptor kinase B (TrkB), (Cell Signaling
Technologies, #4607S, RRID:AB_2155128 1:100); mouse
monoclonal anti-Neurofilament H Non-Phosphorylated
(SMI-32; EMD-Millipore, #NE1023, RRID:AB_2043449,
1:200). Subsequently slices were PBS-washed and
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incubated with secondary antibodies diluted in blocking/
permeabilizing solution for 2 h at room temperature (RT)
in the dark. The secondary antibodies we used were: Alexa
635 goat anti-mouse (Invitrogen, #A31574, RRI-
D:AB_2536184, 1:250); Alexa 488 goat anti-mouse (Invi-
trogen, #A11001, RRID:AB_2534069, 1:400); Alexa 546
goat anti-mouse (Invitrogen, #A11003, RRID:AB_141370,
1:400); Alexa 488 donkey anti-rabbit (Abcam, #ab150061,
RRID:AB_2571722, 1:300). Samples were PBS-washed and
mounted on glass slides with ProLong® Diamond Antifade
Mountant with DAPI (Thermo Fisher Scientific). Stained
samples were examined with 20× and 40× magnification
on a Laser Scanning Confocal Microscopy (LSM 5109
Meta, ZEISS); sections were acquired at different focal
planes every 1 μm. The image analyses were performed
using the ImageJ software (http://rsbweb.nih.gov/ij/).
Western blot analysis
Organotypic slices (n = 5 for each experimental condition)
were lysed with RIPA buffer (50mM Tris-HCl, pH 7.4;
150mM NaCl; 2 mM EDTA; 1mM NaF; 1 mM sodium
orthovanadate, 1% NP-40) in the presence of phosphatase
inhibitor cocktail 2 and 3, protease inhibitor cocktail
(Sigma Aldrich) and centrifuged at 12.000 r.p.m. for 15
min. 40 μg of total proteins were loaded into SDS-PAGE
and blotted onto nitrocellulose filters (GE Healthcare,
Fairfield, CT, USA). Membranes were stained with rabbit
anti-TrkA, anti-TrkB, anti-MKP-1, anti-ERK ½, anti-P-
p38 (Cell Signaling), mouse anti-GAPDH (Cell Signaling),
mouse anti-α-tubulin (Santa Cruz Biotechnology); all the
antibodies were used at 1:1000, final dilution. HRP-
coniugated anti-rabbit IgG (GE Healthcare) or HRP-
conjugated anti mouse IgG (Santa Cruz Biotechnology)
were used as secondary antibodies at 1:2000 final dilution.
The reactions were visualized by the ECL detection system
as recommended by the manufacturer (GE Healthcare).
Electrophysiological recordings
For patch clamp recordings (whole-cell) a coverslip with
the spinal culture was positioned in a recording cham-
ber, mounted on an inverted microscope (Nikon Eclipse
TE200 and Nikon Eclipse Ti-U), and superfused with a
standard saline solution containing (in mM): 152 NaCl,
4 KCl, 1 MgCl2, 2 CaCl2, 10 HEPES and 10 glucose. The
pH was adjusted to 7.4 with NaOH (osmolarity
305 mOsm). Visually identified ventral interneurons
were patched with pipettes (4–7 MΩ) filled with a solu-
tion of the following composition (in mM): 120 K gluco-
nate, 20 KCl, 10 HEPES, 10 EGTA, 2 MgCl2, 2 Na2ATP.
The pH was adjusted to 7.3 with KOH (295 mOsm). All
recordings were performed at RT.
Under voltage clamp configuration, the voltage values
indicated are corrected for the liquid junction potential
(−14 mV) [14] if not otherwise indicated. Series
resistance values were < 10 MΩ enabling recordings of
synaptic currents without significant distortion, and
were not compensated for [13]. Recordings were
performed from ventrally located spinal interneurones
identified on the basis of previously reported criteria [13,
60, 61]. Electrophysiological responses were amplified
(EPC-7, HEKA; Multiclamp 700B, Axon Instruments),
sampled and digitized at 10 kHz with the pCLAMP
software (Axon Instruments) for offline analysis.
In voltage-clamp recordings, single spontaneous post-
synaptic currents (sPSCs) were detected by the use of
the AxoGraph X (Axograph Scientific) event detection
program [62] and by the Clampfit 10 software (pClamp
suite, Axon Instruments). On average, ≥ 400 events were
analysed from each cell in order to obtain mean kinetic
and amplitude parameters. From the average of these
events we measured the rise time defined as the 10–90%
time needed to reach the peak of the synaptic current,
the peak amplitude and the decay time constant
(expressed as τ) by fitting a mono-exponential function.
We detected no differences in membrane capacitance
(45 ± 21 pF CTRL, 46 ± 19 pF CKs4H, 48 ± 18 pF
CKs6H; n = 55, 41, 39, respectively; and 48 ± 21 pF
CTRL +MT2, 43 ± 16 pF CKs4H +MT2, 46 ± 24 pF
CKs6H +MT2; n = 53, 47, 47, respectively) and input
membrane resistance (417 ± 247 MΩ CTRL, 415 ± 328
MΩ CKs4H, 424 ± 404 MΩ CKs6H; and 400 ± 354 MΩ
CTRL +MT2, 430 ± 309 MΩ CKs4H +MT2, 407 ± 244
MΩ CKs6H +MT2) of ventral spinal interneurons
recorded in the different conditions. GABAergic post-
synaptic currents (IPSCs) were recorded at −84 mV
holding potential in the presence of CNQX (10 μM;
Sigma), strychnine (1 μM; Sigma) and APV (25 μM;
Sigma) and tetrodotoxin (TTX; 1 μM, Latoxan) was used
to isolate GABAA receptor-mediated miniature events
(mIPSCs). GABAA receptor-mediated PSCs were fully
blocked by the application of 10 μM SR-95531 (Sigma).
AMPA-glutamate receptor-mediated PSCs were recorded
at −70 mV holding potential in the presence of strychnine
(1 μM; Sigma) and bicuculline (10 μM; Sigma), and TTX
(1 μM, Latoxan) was used to isolate AMPA-glutamate
receptor-mediated miniature events (mEPSCs). AMPA-
glutamate receptor-mediated PSCs were fully blocked by
the application of 10 μM CNQX (Sigma).
During current clamp recordings, bridge balancing
was continuously monitored and adjusted [13]. Action
potentials (APs) were isolated off line by setting an
appropriate threshold (−34 mV). The fast (~ 3 ms dur-
ation) voltage transients that crossed this threshold were
identified as APs. The spontaneous firing frequency for
each neuron was calculated on a sample of at least
5 min of continuous recording at −74 mV resting mem-
brane potential. APs threshold was experimentally deter-
mined by depolarizing current steps [63].
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Induced AP discharge patterns were investigated by
delivering depolarizing current steps (500 ms duration)
of 0.1–0.2 nA amplitude while keeping the cells at
−74 mV resting potential with steady intracellular
current injection. We did not detect differences between
all the conditions tested in neither interneuron resting
membrane potential (−64 ± 9 mV CTRL, −65 ± 9 mV
CKs4H, −63 ± 12 mV CKs6H; n = 21, 16, 16, respectively;
and −66 ± 8 mV CTRL +MT2, −68 ± 6 mV CKs4H +
MT2, −64 ± 7 pF CKs6H +MT2; n = 24, 21, 22, respect-
ively), nor in the spike threshold (−53 ± 4 mV CTRL,
−54 ± 5 mV CKs4H, −53 ± 5 mV CKs6H; and −51 ±
5 mV CTRL +MT2, −53 ± 4 mV CKs4H +MT2, −52 ±
3 mV CKs6H +MT2). Electrophysiological data were ob-
tained from 20 different culture series.
Cytokines and chemokines measurement
IL6, IL10, CCL2, CXCL1, CXCL10 and CXCL2 concentra-
tions were measured in organotypic culture supernatants
by Milliplex assay (Merck Millipore, #MCYTOMAG-
70 k), using the Bio-Plex apparatus (Biorad), according to
the manufacturer’s recommendations.
Statistical analysis
All values from samples subjected to the same experimental
protocols were pooled together and results are presented as
mean ± S.D., if not otherwise indicated; n = number of neu-
rons. Two-way analysis of variance (two-way ANOVA) and
one-way ANOVA were used to determine significance
when multiple groups were compared. Statistical signifi-
cance was determined at P < 0.05.
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constant and rise time of IPSCs in all the conditions tested. (TIFF 777 kb)
Additional file 3: Miniature inhibitory PSCs were faster after CKs
treatments. Box-plots summarize the decay time constant values of
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